Please login to the form below
Biopharm
This page shows the latest Biopharm news and features for those working in and with pharma, biotech and healthcare.
Genactis, emotive and Initiate join forces to create Synaptic Health
It has been clear that our clients, whether large pharma, medtech or biopharm, require a broad range of services to help them successfully develop, launch and maintain products,” said Chris Edmonds,
Latest news
-
New drugs drive Novo Nordisk despite insulin price pressures
The sales growth was supported by increased sales of new products in its diabetes and obesity franchise, as well as its biopharm business.
-
Transgene slumps as viral cancer therapy fails phase 3 trial
have tied up with Turnstone Biologics and BeneVir Biopharm, respectively.
-
AZ invests more in IO with Transgene oncolytic virus deal
Companies such as AbbVie and J&J both struck deals in the field last year with biotech firms – Turnstone Biologics and BeneVir Biopharm respectively.
-
J&J moves quickly ahead with trials of myeloma CAR-T
Earlier this month it bought oncolytic virus player Benevir Biopharm for $140m upfront and up to $900m in milestones, and also has a collaboration with Aduro for cancer vaccine ADU-214
-
J&J pays $140m upfront for cancer-busting virus firm BeneVir
Johnson &Johnson’s initial push into immuno-oncology is gathering pace with an agreement to acquire BeneVir Biopharm and a portfolio of oncolytic viruses designed to infect and destroy tumour cells.
More from news
Approximately 0 fully matching, plus 12 partially matching documents found.
Latest Intelligence
-
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott. ... Biopharm. “We have growth across all the lines we have; new products as well as new versions of existing products.
-
Cell and gene therapy
This view is shared by Andrew Sinclair, managing director of consulting organisation BioPharm Services, who said cell therapies in particular are costly because of the processes used to manufacture them.
-
Cancer immunotherapy: What's on the horizon?
Meanwhile, AbbVie and Johnson &Johnson have both struck deals this year with biotechs in this field – Turnstone Biologics and BeneVir Biopharm respectively – suggesting the oncolytic virus sector is heating up.
More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest appointments
-
Envision Pharma Group announces changes in its executive team
Thompson joined Envision when the group acquired Alligent Biopharm Consulting back in September 2015.
-
Health comms agency emotive hires new cell and gene therapy leader
this incredible moment and play an important role supporting the biopharm companies pioneering in this field.”.
-
Bedrock appoints new commercial director
Dr Laura Ciccolini brings experience from the Biopharm Group and Sigma Aldrich.
-
Bartenbach adds to healthcare management team
Clients include Novartis, Novo Nirdisk and R-Biopharm.
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Key2 Biopharm
Key2 Biopharm specialises in life sciences event management and consultancy, as well as the provision of training courses for pharmaceutical and biotechnology companies. ... Twenty years of sector experience, combined with a passion for excellent service,
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
PMHub
Empowering Strategic Performance Ltd
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
